Clinical Trial Update: A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the topical SXR1096 cream for Netherton syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• SXR1096

Snippet

Sponsor: Sixera Pharma | Conditions: Netherton Syndrome | Phase 1, Phase 2 | Status: COMPLETED